Replies to post #599804 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

I also believe the regulatory authorities do understand the concept of “which comes first, the chicken or the egg”. In the case of NWBio and DCVax-L, the question would be, “which comes first, approvals to generate revenue and capital, or adequate manufacturing capacity to meet future demands?

Exactly. Expecting NWBO to pay for the latter on speculation alone as if they were a Big Pharma operation is as foolish as it is inherently unfair.

[skitahoe]

ATL, I may be wrong, but others here have estimated that the EDEN unit will cost in the tens of thousands. If this is correct, the first batch of vaccine made by the unit will more than pay for it. I believe that CRL has many existing facilities that potentially could house many units that already have most of the equipment needed to do so. Certainly, some new large cleanrooms would have to be added, but most of the rest is present in the existing facilities. I am only suggesting that the cost may not be as great as you think.

Gary